Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Forecast for the Albumin Excipient Market Growth in 2025?

There has been a significant growth in the albumin excipient market size in the past few years. It is projected to increase from $4.85 billion in 2024 to $5.2 billion in 2025, with a compound annual growth rate (CAGR) of 7.1%. The past growth patterns can be attributed to factors such as the proliferation of the biopharmaceutical industry, a surge in the adoption of biologics, an increase in chronic diseases, advancements in clinical practices, drug innovation, and a heightened focus on drug delivery.

What Is the Forecast for the Albumin Excipient Market Size Through 2029?

The market size for albumin excipient is projected to experience robust growth in the upcoming years, with an estimated value of “$6.77 billion by 2029 and a compound annual growth rate (CAGR) of 6.8%. The predicted expansion through the forecast period is largely due to continuous advancement in biopharmaceuticals, an enlarged biologics pipeline, an increasing older population, worldwide vaccine efforts, and a rise in investment for drug development. Noteworthy trends throughout this prediction period also include biodegradable and biocompatible attributes, cooperative efforts and partnerships in studies, adherence to regulatory and quality standards, application in cell treatment, as well as the incorporation of custom and made-to-order solutions.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10672&type=smp

What are the Key Market Players in Albumin Excipient Market and How They’re Evolving?

Major companies operating in the albumin excipient market include Albumin Therapeutics LLC, Biotest AG, CSL Behring,Grifols S.A., HiMedia Laboratories LLC, InVitria Inc., Medxbio Pte Ltd., Octapharma AG, RayBiotech Inc., SeraCare Life Sciences Inc., Sigma-Aldrich Pty. Ltd., Hualan Biological Engineering Inc., Kedrion Biopharma, LFB USA Inc., Shanghai RAAS Blood Products Co. Ltd., Baxter International Inc., Merck KGaA, Thermo Fisher Scientific Inc., Albumedix A/S, Bio Products Laboratory Ltd., Shire Plc., Ventria Bioscience Inc., Novartis AG, China Biologic Products Holdings Inc., ProMetic Life Sciences Inc., Sanquin, Biopharma, Takeda Pharmaceutical Company Limited, FUJIFILM Irvine Scientific Inc.

What Are the Primary Growth Drivers in the Albumin Excipient Market?

The escalating occurrence of chronic diseases is anticipated to boost the expansion of the albumin excipient market in the future. Chronic diseases are illnesses that persist for at least three months or longer and may progressively worsen over time. Albumin, the most prevalent circulating protein in plasma, is employed as a blood volumizer. It serves as a versatile protein transporter for drug targeting and ameliorating the pharmacokinetic profile of peptide or protein-based medications. These play a crucial role in treating a range of diseases, such as cancer and diabetes. For example, according to the World Health Organization, a United Nations agency based in Switzerland, it was forecasted in February 2024 that there would be an increase of 77% or over 35 million new cancer cases by 2050, compared to an estimated 20 million in 2022. Thus, the escalating occurrence of chronic diseases is fueling the expansion of the albumin excipient market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=10672&type=smp

What Are the Leading Segments in the Global Albumin Excipient Industry?

The albumin excipient market covered in this report is segmented –

1) By Product: Human Serum Albumin, Recombinant Albumin

2) By End-Users: Pharmaceutical And Biotechnology Industry, Research Institutes, Other End Users

Subsegments:

1) By Human Serum Albumin: 5% Human Serum Albumin, 20% Human Serum Albumin

2) By Recombinant Albumin: Recombinant Human Serum Albumin, Recombinant Bovine Serum Albumin

What Are the Key Market Trends in the Albumin Excipient Industry?

Key players in the albumin excipient market, such as ARTES Biotechnology GmbH in Germany and Basic Pharma, based in the Netherlands, have opted for strategic partnerships as a business strategy. Granting companies the opportunity to take advantage of each other’s strengths and resources for mutual benefits, these partnerships permit improved delivery in essential areas of biotechnology and pharmaceuticals. An example of this can be seen in October 2023 when ARTES Biotechnology GmbH and Basic Pharma collaborated to enhance the production of recombinant proteins. This new partnership aims to refine the supply chain, reducing the time-to-market for new product launches.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/albumin-excipient-global-market-report

What Is the Regional Outlook for the Albumin Excipient Market?

North America was the largest region in the Albumin Excipient market in 2024.Asia-Pacific is expected to be the fastest-growing region in the global albumin excipient market report during the forecast period. The regions covered in the albumin excipient market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10672

This Report Delivers Insight On:

1. How big is the albumin excipient market, and how is it changing globally?

2. Who are the major companies in the albumin excipient market, and how are they performing?

3. What are the key opportunities and risks in the albumin excipient market right now?

4. Which products or customer segments are growing the most in the albumin excipient market?

5. What factors are helping or slowing down the growth of the albumin excipient market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model